menu
    • menu

    Company profile for Recce Pharmaceuticals

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    An Emerging Global Leader in the New Generation of Anti-Infective Therapies. Recce Pharmaceuticals Ltd (ASX: RCE) are pioneering a new class of synthetic anti-infectives to address the urgent global health threat posed by superbugs and emerging viral pathogens. RECCE® 327 and RECCE® 529 have been designed with a unique mechanism of action, with the goal of re-empowering physicians in their potential of an effective treatm...
    An Emerging Global Leader in the New Generation of Anti-Infective Therapies. Recce Pharmaceuticals Ltd (ASX: RCE) are pioneering a new class of synthetic anti-infectives to address the urgent global health threat posed by superbugs and emerging viral pathogens. RECCE® 327 and RECCE® 529 have been designed with a unique mechanism of action, with the goal of re-empowering physicians in their potential of an effective treatment that may be used repeatedly against a broad range of bacteria and viruses. RECCE® 529 is a new synthetic polymer formulation with indication against viruses.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Recce PharmaceuticalsAustralia Flag
    Country
    Country
    Australia
    Address
    Address
    Level 36, 1 Macquarie Place Gateway Tower, SYDNEY NSW 2000
    Telephone
    Telephone
    +61 (2) 8075 4585
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.recce.com.au/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/reccepharmaceuticals/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/ReccePharma

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    Global ChemShow

    Not Confirmed

    envelop Contact Supplier

    Global ChemShow

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Recce Pharma Approved for Phase II Trial of RECCE® 327 Topical Gel
    Recce Pharma Approved for Phase II Trial of RECCE® 327 Topical Gel

    23 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/23/3066318/0/en/Recce-Pharmaceuticals-Receives-Approval-for-Additional-Phase-II-Trial-of-RECCE-327-Topical-Gel-for-Diabetic-Foot-Infections.html

    GLOBENEWSWIRE
    23 Apr 2025
    Share Share
    Recce Pharmaceuticals Announces A$5.0M Placement & A$10.8M Offer
    Recce Pharmaceuticals Announces A$5.0M Placement & A$10.8M Offer

    10 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/10/3059191/0/en/Recce-Pharmaceuticals-Announces-A-5-0-million-Placement-Launches-A-10-8-million-Entitlement-Offer-to-Shareholders.html

    GLOBENEWSWIRE
    10 Apr 2025
    Share Share
    Recce Pharma Granted Japanese Patent for RECCE Anti-Infectives
    Recce Pharma Granted Japanese Patent for RECCE Anti-Infectives

    27 Feb 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/02/27/3033826/0/en/Recce-Pharmaceuticals-Granted-Japanese-Patent-for-RECCE-Anti-Infectives.html

    GLOBENEWSWIRE
    27 Feb 2025
    Share Share
    Recce Reports Positive Ph 2 Data For RECCE 327 In Bacterial Skin Infections
    Recce Reports Positive Ph 2 Data For RECCE 327 In Bacterial Skin Infections

    19 Feb 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2025/02/19/3028726/0/en/Recce-Pharmaceuticals-Reports-Positive-Data-from-Phase-II-Trial-of-RECCE-327-Gel-in-Acute-Bacterial-Skin-and-Skin-Structure-Infections-Supporting-Accelerated-Commercialization-Path.html

    GLOBENEWSWIRE
    19 Feb 2025
    Share Share
    Recce Doses All Patients In Phase II Trial Of RECCE® 327 Gel
    Recce Doses All Patients In Phase II Trial Of RECCE® 327 Gel

    22 Jan 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/01/22/3013447/0/en/Recce-Pharmaceuticals-Doses-All-Patients-in-Phase-II-Trial-of-RECCE-327-Topical-Gel-in-Acute-Bacterial-Skin-and-Skin-Structure-Infections.html

    GLOBENEWSWIRE
    22 Jan 2025
    Share Share
    Recce Receives Approval for Ph 3 Diabetic Foot Infection Trial
    Recce Receives Approval for Ph 3 Diabetic Foot Infection Trial

    10 Dec 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/12/10/2994510/0/en/Recce-Pharmaceuticals-Receives-Approval-from-Indonesia-s-Drug-and-Food-Authority-for-Registrational-Phase-3-Trial-of-RECCE-327-Topical-Gel-in-Diabetic-Foot-Infections.html

    GLOBENEWSWIRE
    10 Dec 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search